Oruka Therapeutics (ORKA) Change in Taxes (2018 - 2019)
Oruka Therapeutics (ORKA) posted quarterly Change in Taxes of $16000.0 for Q4 2019, down 30.43% year-over-year from $23000.0 in Q4 2018, and down 61.9% quarter-over-quarter from $42000.0 in Q3 2019.
Powered by 
Analysis
Oruka Therapeutics (ORKA) Change in Taxes (2018 - 2019) Analysis & Trends
Oruka Therapeutics' Change in Taxes history runs 2 years deep, the most recent figure standing at $16000.0 for Q4 2019.
- In Q4 2019, Change in Taxes fell 30.43% year-over-year to $16000.0; the TTM figure through Dec 2020 stood at $58000.0 (down 65.27% YoY), while the FY2020 annual figure was $9000.0, down 94.61% from the prior year.
- Change in Taxes for Q4 2019 stood at $16000.0, down from $42000.0 in the prior quarter.
- The five-year high for Change in Taxes was $82000.0 in Q1 2019, with the low at $16000.0 in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Oruka Therapeutics | 5.89 Bn | 4.16 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 16,000.00 |
| Sep 30, 2019 | 42,000.00 |
| Jun 30, 2019 | 27,000.00 |
| Mar 31, 2019 | 82,000.00 |
| Dec 31, 2018 | 23,000.00 |